SANGAMO THERAPEUTICS, INC - SGMO
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$98K
QoQ value delta ($000)
-$26.54M
(-99.63%)
Implied price effect (QoQ)
-76.3%
Shares
Total shares
1,677,479
QoQ shares delta
-106,363,974
(-98.45%)
Total shares held by funds (by quarter)
Market chart (SGMO)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 7 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| JANE STREET GROUP, LLC | 32 | 609,900 | 0.0% |
| SIMPLEX TRADING, LLC | 29 | 555,000 | 0.0% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 22 | 400,000 | 0.0% |
| VectorGlobal IAG, Inc. | 7 | 30,838 | 0.0% |
| Sandbox Financial Partners, LLC | 6 | 24,833 | 0.0% |
| FLOW TRADERS U.S. LLC | 1 | 21,532 | 0.0% |
| Axiom Investment Management LLC | 1 | 25,375 | 0.0% |
| BARCLAYS PLC | 0 | 1 | 0.0% |
| Heritage Investment Group, Inc. | 0 | 10,000 | 0.0% |